Project Grant ED20HDQ0200016

The Center for Advancing Innovation, Inc. was awarded a $2.49 million project grant from the Department of Commerce Economic Development Administration under the BUILD TO SCALE federal grant program (CFDA 11.024) to launch the Global Health Innovation Challenge. Over three years, the Center will source and launch over 60 high-growth startups in the Washington D.C. metro area to address global health threats using technology. The startups will focus on preventing, diagnosing, treating and...

The Defense Health Agency awarded Emory University a $156,500 project grant under the Military Medical Research and Development program to support research on core transcription factors in regenerative medicine and cancer. The one-year award beginning September 30, 2023 will fund investigation into medical solutions for the battlefield by transforming healthcare through innovative biomedical research. Specifically, Emory University will conduct research on core transcription factors as they...

The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,857,470 Cooperative Agreement to The Geneva Foundation to develop a multiplex testing platform that can simultaneously detect and identify Plasmodium species infections. This platform will serve as both a diagnostic tool and an epidemiological surveillance tool. The project performance period is from June 1, 2024 to May 31, 2028. Under a $268,312 sub-award, Meso Scale...

The Department of the Army Medical Command awarded a $1,363,356 project grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) to determine the molecular basis and therapeutic potential of hyperactive stem cell programs in colorectal cancer. This funding supports the Military Medical Research and Development program (CFDA #12.420), which aims to transform military and public health through innovative biomedical research and investigate medical solutions for battlefield wounds. Over...

The Defense Health Agency has awarded a $657,263 project grant under the Military Medical Research and Development program (CFDA 12.420) to the Dana-Farber Cancer Institute, Inc. (d.b.a. DFCI) in Boston, MA. The award, effective September 1, 2024 through August 31, 2027, will support DATA-DRIVEN BIOMARKER-INFORMED DECISION ANALYTICS IN MELANOMA: IMPROVING EFFICACY AND REDUCING TOXICITY OF IMMUNE CHECKPOINT BLOCKADE. Through this grant, DFCI will conduct research to develop data-driven...

This $775,000 Project Grant from the Defense Health Agency under the CFDA 12.420 Military Medical Research and Development program supports research at Wake Forest University Health Sciences (WFUHS) to model airborne hazard exposures using an airway-on-a-chip platform. The goal is to elucidate common pathophysiological mechanisms and identify potential medical countermeasure targets. This 3-year research project, starting on September 1, 2023, will leverage WFUHS's expertise in biomedical...

The Defense Health Agency awarded a $562,500 project grant to Captis Diagnostics Inc., a self-certified small disadvantaged business, to develop an extracellular vesicle-based liquid biopsy assay for predicting pathological complete response in breast cancer patients. The grant project runs from April 1, 2024 to March 31, 2027 and is funded through the Military Medical Research and Development program (CFDA 12.420). This program supports a range of biomedical research to improve health...

The Economic Development Administration awarded a $1.2 million Project Grant to the University of Nebraska Medical Center under the BUILD TO SCALE federal grant program (CFDA 11.024) to fund the Omaha Medical Technology Development Alliance project from November 1, 2022 through October 31, 2025. The project will identify, educate, and connect potential sources of equity capital within the Omaha medical technology cluster to startup companies through investor discovery, outreach, and education...

The Department of the Army Medical Command awarded a $884,997 Project Grant to the Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program. The three-year grant will fund research to intervene in the TP53 pathway phosphatome in pediatric high-grade gliomas. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research that investigates medical solutions...

This Project Grant from the Defense Health Agency provides $734,781 to Formation Venture Engineering Foundry Inc. for precision medicine immunotherapy research under the Military Medical Research and Development program (CFDA 12.420). The research aims to develop medical solutions for treating neurodegeneration in amyotrophic lateral sclerosis patients who test positive for human endogenous retrovirus K. The awardee will conduct applied and advanced biomedical research from June 2023 through...